Diet and Nutrition
522 articles
Two Enzymes May Predict Pancreatic Cancer Severity and Development
Dr. Alexandra Newton and her lab have found that the relationship between two enzymes common to cancer may play a role in pancreatic cancer prognosis.
A New Radiation Therapy Helped Me Beat Cancer
Connie Harrington’s tumor was wrapped around an artery, eliminating surgery. After chemo, her oncologist steered her to MRI-guided radiation, which has made all the difference.
I Wanted Immunotherapy!
When Daniel Miller was diagnosed with pancreatic cancer he knew he didn’t want chemotherapy—he wanted immunotherapy!
Three Ways to Be your Own Best Health Advocate
Leslie Michelson recommends putting together a health care team of friends, advocates and physicians for the best possible care after a cancer diagnosis.
Another Day to Live
Marc Binder is living with stage IV pancreatic cancer, thanks to a personalized treatment plan that allows him to keep active.
Advocating For My Own Future
Kay Kays is a long-term survivor of pancreatic cancer who has learned to advocate for herself to get the treatments she needs.
Diagnosed Early
Because Anthony Rafaniello had recurring pancreatitis, he paid close attention when he started to feel sick. The result: pancreatic cancer diagnosed early.
Why You Need This Simple Blood Test at Diagnosis
An important factor in determining which treatment to use for pancreatic cancer patients is measuring the level of tumor marker CA-19-9. Learn more here.
Novel Drug Therapy Kills Pancreatic Cancer Cells by Reducing Levels of Antioxidants
New research finds that reducing antioxidants can help kill pancreatic cancer cells, suggesting a new direction for treatment.
Platinum-Based Therapy Can Significantly Improve Survival for Some Pancreatic Cancer Patients
Dr. Michael Pishvaian explains how platinum-based therapy can improve the survival of pancreatic cancer patients with a specific mutation.
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
COMBATing Pancreatic Cancer
Dr. Manuel Hidalgo explains the COMBAT trial, which combines immunotherapy, a checkpoint inhibitor, and chemotherapy to attack pancreatic cancer.
Disappointing Results of a Phase II Trial Using Angiogenesis Inhibitor
Dr. Tanios Bekaii-Saab reports on the disappointing results of a trial combining an angiogenesis inhibitor and mFOLFIRINOX.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
Screening Programs Save High-Risk People
Dr. Michael Goggins explains who should undergo regular pancreatic cancer screening and where programs can be found.